Pang Q - Search Results

1

Serum Irisin Levels Are Positively Correlated with Physical Activity Capacity in Hemodialysis Patients.

Fan Z, Wu F, Wang P, Wu L, Zhang J, Li W, Pang Q, Zhang A. Fan Z, et al. Among authors: pang q. Kidney Blood Press Res. 2025 Jan 3:1-19. doi: 10.1159/000543214. Online ahead of print. Kidney Blood Press Res. 2025. PMID: 39756383 Free article.

2

Irisin Ameliorated Skeletal Muscle Atrophy by Inhibiting Fatty Acid Oxidation and Pyroptosis Induced by Palmitic Acid in Chronic Kidney Disease.

Zhou T, Wang S, Pan Y, Dong X, Wu L, Meng J, Zhang J, Pang Q, Zhang A. Zhou T, et al. Among authors: pang q. Kidney Blood Press Res. 2023;48(1):628-641. doi: 10.1159/000533926. Epub 2023 Sep 15. Kidney Blood Press Res. 2023. PMID: 37717561 Free PMC article.

3

Serum irisin level is higher in peritoneal dialysis than in hemodialysis.

Song XY, Zhou SJ, Zhang JL, Zhou T, Wang SY, Pang Q, Pan YJ, Zhang AH. Song XY, et al. Among authors: pang q. Int Urol Nephrol. 2023 May;55(5):1329-1334. doi: 10.1007/s11255-022-03440-w. Epub 2022 Dec 17. Int Urol Nephrol. 2023. PMID: 36527594

4

Irisin Alleviates Cognitive Impairment by Inhibiting AhR/NF-κB-NLRP3-Mediated Pyroptosis of Hippocampal Neurons in Chronic Kidney Disease.

Zhang J, Dong X, Pang Q, Zhang A. Zhang J, et al. Among authors: pang q. Mediators Inflamm. 2024 Dec 11;2024:2662362. doi: 10.1155/mi/2662362. eCollection 2024. Mediators Inflamm. 2024. PMID: 39698584 Free PMC article.

5

Handgrip strength is associated with cognitive function in older patients with stage 3-5 chronic kidney disease: results from the NHANES.

Zhang J, Wang P, Pang Q, Wang S, Zhang A. Zhang J, et al. Among authors: pang q. Sci Rep. 2024 May 6;14(1):10329. doi: 10.1038/s41598-024-60869-y. Sci Rep. 2024. PMID: 38710751 Free PMC article.

6

Associated factors of cardiac valve calcification and its prognostic effects among patients with chronic kidney disease: a systematic review and meta-analysis.

Zhang J, Pang Q, Wang S, Wu L, Zhang A. Zhang J, et al. Among authors: pang q. Front Cardiovasc Med. 2023 Apr 26;10:1120634. doi: 10.3389/fcvm.2023.1120634. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37180797 Free PMC article. Review.

7

Irisin Ameliorates Muscle Atrophy by Inhibiting the Upregulation of the Ubiquitin‒Proteasome System in Chronic Kidney Disease.

Wang S, Pan Y, Pang Q, Zhang A. Wang S, et al. Among authors: pang q. Calcif Tissue Int. 2024 Nov;115(5):712-724. doi: 10.1007/s00223-024-01283-4. Epub 2024 Sep 16. Calcif Tissue Int. 2024. PMID: 39283327

8

Irisin alleviates vascular calcification by inhibiting VSMC osteoblastic transformation and mitochondria dysfunction via AMPK/Drp1 signaling pathway in chronic kidney disease.

Wang PW, Pang Q, Zhou T, Song XY, Pan YJ, Jia LP, Zhang AH. Wang PW, et al. Among authors: pang q. Atherosclerosis. 2022 Apr;346:36-45. doi: 10.1016/j.atherosclerosis.2022.02.007. Epub 2022 Feb 16. Atherosclerosis. 2022. PMID: 35255258 Free article.

9

Irisin protects against vascular calcification by activating autophagy and inhibiting NLRP3-mediated vascular smooth muscle cell pyroptosis in chronic kidney disease.

Pang Q, Wang P, Pan Y, Dong X, Zhou T, Song X, Zhang A. Pang Q, et al. Cell Death Dis. 2022 Mar 30;13(3):283. doi: 10.1038/s41419-022-04735-7. Cell Death Dis. 2022. PMID: 35354793 Free PMC article.

10

Risk factors for acute kidney injury in COVID-19 patients: an updated systematic review and meta-analysis.

Zhang J, Pang Q, Zhou T, Meng J, Dong X, Wang Z, Zhang A. Zhang J, et al. Among authors: pang q. Ren Fail. 2023 Dec;45(1):2170809. doi: 10.1080/0886022X.2023.2170809. Ren Fail. 2023. PMID: 37021610 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,403 results

Search Page

Filters